Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Thermostability and reversibility of silver nanoparticle-protein binding.

Wang B, Seabrook SA, Nedumpully-Govindan P, Chen P, Yin H, Waddington L, Epa VC, Winkler DA, Kirby JK, Ding F, Ke PC.

Phys Chem Chem Phys. 2015 Jan 21;17(3):1728-39. doi: 10.1039/c4cp04996a. Epub 2014 Dec 2.

PMID:
25461673
2.

Modelling human embryoid body cell adhesion to a combinatorial library of polymer surfaces.

Epa VC, Yang J, Mei Y, Hook AL, Langer R, Anderson DG, Davies MC, Alexander MR, Winkler DA.

J Mater Chem. 2012 Sep 18;22(39):20902-20906.

3.

Structural model for the interaction of a designed Ankyrin Repeat Protein with the human epidermal growth factor receptor 2.

Epa VC, Dolezal O, Doughty L, Xiao X, Jost C, Pl├╝ckthun A, Adams TE.

PLoS One. 2013;8(3):e59163. doi: 10.1371/journal.pone.0059163. Epub 2013 Mar 19.

4.

Modeling biological activities of nanoparticles.

Epa VC, Burden FR, Tassa C, Weissleder R, Shaw S, Winkler DA.

Nano Lett. 2012 Nov 14;12(11):5808-12. doi: 10.1021/nl303144k. Epub 2012 Oct 9.

PMID:
23039907
5.

Quantitative structure-property relationship modeling of diverse materials properties.

Le T, Epa VC, Burden FR, Winkler DA.

Chem Rev. 2012 May 9;112(5):2889-919. doi: 10.1021/cr200066h. Epub 2012 Jan 17. Review. No abstract available.

PMID:
22251444
6.

Ligand-binding properties of a juvenile hormone receptor, Methoprene-tolerant.

Charles JP, Iwema T, Epa VC, Takaki K, Rynes J, Jindra M.

Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):21128-33. doi: 10.1073/pnas.1116123109. Epub 2011 Dec 13.

7.

Binding inhibitors of the bacterial sliding clamp by design.

Wijffels G, Johnson WM, Oakley AJ, Turner K, Epa VC, Briscoe SJ, Polley M, Liepa AJ, Hofmann A, Buchardt J, Christensen C, Prosselkov P, Dalrymple BP, Alewood PF, Jennings PA, Dixon NE, Winkler DA.

J Med Chem. 2011 Jul 14;54(13):4831-8. doi: 10.1021/jm2004333. Epub 2011 Jun 7.

PMID:
21604761
8.

Glioma Specific Extracellular Missense Mutations in the First Cysteine Rich Region of Epidermal Growth Factor Receptor (EGFR) Initiate Ligand Independent Activation.

Ymer SI, Greenall SA, Cvrljevic A, Cao DX, Donoghue JF, Epa VC, Scott AM, Adams TE, Johns TG.

Cancers (Basel). 2011 Apr 18;3(2):2032-49. doi: 10.3390/cancers3022032.

9.

The structure of the amyloid-beta peptide high-affinity copper II binding site in Alzheimer disease.

Streltsov VA, Titmuss SJ, Epa VC, Barnham KJ, Masters CL, Varghese JN.

Biophys J. 2008 Oct;95(7):3447-56. doi: 10.1529/biophysj.108.134429. Epub 2008 Jul 3.

10.

The location and characterisation of the O-linked glycans of the human insulin receptor.

Sparrow LG, Gorman JJ, Strike PM, Robinson CP, McKern NM, Epa VC, Ward CW.

Proteins. 2007 Feb 1;66(2):261-5.

PMID:
17078079
11.

Structure of the insulin receptor ectodomain reveals a folded-over conformation.

McKern NM, Lawrence MC, Streltsov VA, Lou MZ, Adams TE, Lovrecz GO, Elleman TC, Richards KM, Bentley JD, Pilling PA, Hoyne PA, Cartledge KA, Pham TM, Lewis JL, Sankovich SE, Stoichevska V, Da Silva E, Robinson CP, Frenkel MJ, Sparrow LG, Fernley RT, Epa VC, Ward CW.

Nature. 2006 Sep 14;443(7108):218-21. Epub 2006 Sep 6.

PMID:
16957736
12.

The first three domains of the insulin receptor differ structurally from the insulin-like growth factor 1 receptor in the regions governing ligand specificity.

Lou M, Garrett TP, McKern NM, Hoyne PA, Epa VC, Bentley JD, Lovrecz GO, Cosgrove LJ, Frenkel MJ, Ward CW.

Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12429-34. Epub 2006 Aug 7.

13.
14.

The X-ray structure of a hemipteran ecdysone receptor ligand-binding domain: comparison with a lepidopteran ecdysone receptor ligand-binding domain and implications for insecticide design.

Carmichael JA, Lawrence MC, Graham LD, Pilling PA, Epa VC, Noyce L, Lovrecz G, Winkler DA, Pawlak-Skrzecz A, Eaton RE, Hannan GN, Hill RJ.

J Biol Chem. 2005 Jun 10;280(23):22258-69. Epub 2005 Apr 4.

15.

Inhibition of protein interactions with the beta 2 sliding clamp of Escherichia coli DNA polymerase III by peptides from beta 2-binding proteins.

Wijffels G, Dalrymple BP, Prosselkov P, Kongsuwan K, Epa VC, Lilley PE, Jergic S, Buchardt J, Brown SE, Alewood PF, Jennings PA, Dixon NE.

Biochemistry. 2004 May 18;43(19):5661-71.

PMID:
15134440
16.

Structure of the haemagglutinin-neuraminidase from human parainfluenza virus type III.

Lawrence MC, Borg NA, Streltsov VA, Pilling PA, Epa VC, Varghese JN, McKimm-Breschkin JL, Colman PM.

J Mol Biol. 2004 Jan 30;335(5):1343-57.

PMID:
14729348
17.

Enzymic, phylogenetic, and structural characterization of the unusual papain-like protease domain of Plasmodium falciparum SERA5.

Hodder AN, Drew DR, Epa VC, Delorenzi M, Bourgon R, Miller SK, Moritz RL, Frecklington DF, Simpson RJ, Speed TP, Pike RN, Crabb BS.

J Biol Chem. 2003 Nov 28;278(48):48169-77. Epub 2003 Sep 17.

18.

Topological characterization of an inner membrane (1-->3)-beta-D-glucan (curdlan) synthase from Agrobacterium sp. strain ATCC31749.

Karnezis T, Epa VC, Stone BA, Stanisich VA.

Glycobiology. 2003 Oct;13(10):693-706. Epub 2003 Jul 8.

PMID:
12851288
19.

Modeling the epidermal growth factor -- epidermal growth factor receptor l2 domain interaction: implications for the ligand binding process.

Jorissen RN, Treutlein HR, Epa VC, Burgess AW.

J Biomol Struct Dyn. 2002 Jun;19(6):961-72.

PMID:
12023799

Supplemental Content

Loading ...
Support Center